RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCOPUS

    Toward integrated multimodal artificial intelligence in bone marrow examination: current state and open challenges

    한글로보기

    https://www.riss.kr/link?id=A110554851

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
      • URL 복사
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Bone marrow (BM) examinations are intrinsically multimodal: hematopathologists integrate peripheral blood, aspirate cytomorphology, trephine histology, flow cytometry, cytogenetics, and molecular genetics data into a single interpretation. Because WHO-HAEM5 and ICC 2022 define entities through integrated morphological, immunophenotypic, cytogenetic, and molecular criteria, multimodal diagnostic reasoning embedded in a procedural workflow, not isolated image classification, represents the appropriate target for the use of artificial intelligence (AI). We review the existing research on integrated multimodal AI systems for BM examination by classifying these systems into three categories: mature single-modality tools; systems that perform cross-modal prediction, in which one modality is estimated from another; and genuine multimodal fusion systems, in which several modalities are jointly ingested by a single model. Evidence is stronger at the single-modality level, where deep learning approaches expert performance in aspirate cytology, trephine histology, and flow cytometry assessments, and the first Food and Drug Administration (FDA) De Novo–authorized all-digital bone marrow aspirate (BMA) application has defined a new device category. On the other hand, while cross-modal prediction is rapidly expanding, genuine multimodal fused systems that jointly ingest matched morphology, flow, molecular, and clinical data to yield unified guideline-aligned recommendations remain unrealized. Direct head-to-head evidence is sparse and endpoint-dependent; nevertheless, the lack of demonstrated superiority over the strongest single-modality comparator does not automatically imply the absence of benefits. The dominant obstacles are fusion of heterogeneous modalities with missing data, absence of large paired multi-institutional datasets and harmonized nomenclature, class imbalances, batch-effect-driven generalization failures, immature explainability, uncertainty quantification, and regulatory pathways. Nevertheless, integrated multimodal AI systems for BM examinations have entered a promising early translational phase, and the field should aim to pursue integration using paired datasets, explicit fusion architectures, calibrated abstention-aware models, and staged prospective validation.
    번역하기

    Bone marrow (BM) examinations are intrinsically multimodal: hematopathologists integrate peripheral blood, aspirate cytomorphology, trephine histology, flow cytometry, cytogenetics, and molecular genetics data into a single interpretation. Because WHO...

    Bone marrow (BM) examinations are intrinsically multimodal: hematopathologists integrate peripheral blood, aspirate cytomorphology, trephine histology, flow cytometry, cytogenetics, and molecular genetics data into a single interpretation. Because WHO-HAEM5 and ICC 2022 define entities through integrated morphological, immunophenotypic, cytogenetic, and molecular criteria, multimodal diagnostic reasoning embedded in a procedural workflow, not isolated image classification, represents the appropriate target for the use of artificial intelligence (AI). We review the existing research on integrated multimodal AI systems for BM examination by classifying these systems into three categories: mature single-modality tools; systems that perform cross-modal prediction, in which one modality is estimated from another; and genuine multimodal fusion systems, in which several modalities are jointly ingested by a single model. Evidence is stronger at the single-modality level, where deep learning approaches expert performance in aspirate cytology, trephine histology, and flow cytometry assessments, and the first Food and Drug Administration (FDA) De Novo–authorized all-digital bone marrow aspirate (BMA) application has defined a new device category. On the other hand, while cross-modal prediction is rapidly expanding, genuine multimodal fused systems that jointly ingest matched morphology, flow, molecular, and clinical data to yield unified guideline-aligned recommendations remain unrealized. Direct head-to-head evidence is sparse and endpoint-dependent; nevertheless, the lack of demonstrated superiority over the strongest single-modality comparator does not automatically imply the absence of benefits. The dominant obstacles are fusion of heterogeneous modalities with missing data, absence of large paired multi-institutional datasets and harmonized nomenclature, class imbalances, batch-effect-driven generalization failures, immature explainability, uncertainty quantification, and regulatory pathways. Nevertheless, integrated multimodal AI systems for BM examinations have entered a promising early translational phase, and the field should aim to pursue integration using paired datasets, explicit fusion architectures, calibrated abstention-aware models, and staged prospective validation.

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    해외이동버튼